• Vyas DA, James A, Kormos W, Essien UR. Revising the atherosclerotic cardiovascular disease calculator without race. The Lancet. Digital health. 2022 Jan 1; 4(1):e4-e5.
• Sarraju A, Spencer-Bonilla G, Chung S, Gomez S, Li J, Heidenreich P, Palaniappan L, Rodriguez F. Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk. Journal of general internal medicine. 2021 Sep 10.
• Chow SL, Sasson C, Benjamin IJ, Califf RM, Compton WM, Oliva EM, Robson C, Sanchez EJ. Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart Association. Circulation. 2021 Sep 28; 144(13):e218-e232.
• Monach PA, Branch-Elliman W. Aspirin Dosing in Cardiovascular Disease. The New England journal of medicine. 2021 Aug 19; 385(8):764.
• Blumenthal DM, Maddox TM, Aragam K, Sacks CA, Virani SS, Wasfy JH. Predictors of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitor Prescriptions for Secondary Prevention of Clinical Atherosclerotic Cardiovascular Disease. Circulation. Cardiovascular quality and outcomes. 2021 Sep 1; 14(9):e007237.

» View more Citations

• Women Veterans with Premature Cardiovascular Disease Less Likely than Men to Receive Secondary Prevention Therapy
  This study sought to evaluate sex-based differences in antiplatelet use, any statin and high-intensity statin (HIS) therapy, and statin adherence among patients with premature and extremely premature atherosclerotic cardiovascular disease (ASCVD). Findings showed that women Veterans with premature (age < 55 years) and extremely premature (age < 40 years) ASCVD were less likely to receive antiplate...
  
  Date: April 21, 2021
• Many Veterans Unnecessarily Take Low-Dose Aspirin to Prevent Cardiovascular Disease
  The goal of this study was to investigate the suitability of electronic health records (EHR) to identify patients for deprescribing aspirin based on updated guidelines. Findings showed that many Veterans unnecessarily take low-dose aspirin to prevent cardiovascular disease. Between 2% to 5% of Veterans in this study took low-dose aspirin outside of the guidelines and qualify for the definition of ...
  
  Date: December 15, 2020
• VA HIT-Related Outpatient Diagnostic Delays
  This study evaluated the role of health information technology (HIT) in the root cause analyses (RCAs) of outpatient diagnostic delays submitted to the VA National Center for Patient Safety, which leads patient safety initiatives and uses RCAs of adverse events and close calls to promote learning across the VA healthcare system. Findings showed that of the 214 RCAs included in this study, 88 invol...
  
  Date: June 25, 2020
• Cardiovascular Benefits of Intensive Glucose Control in Veterans with Type 2 Diabetes Did Not Persist in Long-term Post-Trial Follow-Up
  Long-term follow-up of glucose lowering in patients with type 2 diabetes may help clarify the duration of any potential cardiovascular disease (CVD) benefit. Investigators here report on the full 15-year follow-up of Veterans with type 2 diabetes who were randomly assigned to receive either intensive or standard glucose control as part of the Veterans Affairs Diabetes Trial. Findings showed that V...
  
  Date: June 6, 2019
• Cardiovascular Care and Research for Women Veterans
  This review presents important information on five areas of cardiovascular disease (CVD) care for women Veterans: 1) rapidly changing demographics; 2) prevalence of traditional risk factors; 3) prevalence of less traditional risk factors (i.e., homelessness, military sexual trauma, and mental health disorders); 4) treatment and outcomes of CVD; and 5) the current state and future directions of wom...
  
  Date: February 19, 2019

» View more Publication Briefs

» View more Studies

• Mindfulness-based Stress Reduction for Women at Risk for Cardiovascular Disease || In Progress

  Reduction for Women at Risk for Cardiovascular Disease Feature Article Evidence demonstrates...processes implicated in coronary artery disease and stroke. Veterans who have experienced

• End-stage Renal Disease and Depression: A Systematic Review

  End-stage Renal Disease and Depression: A Systematic Review...End-stage Renal Disease and Depression: A Systematic Review  January 2020 Prepared...MD, MCR, Director End-stage Renal Disease and Depression: A Systematic Review

• Management Briefs eBrief-no46 -- Treatment of Anemia in Patients with Heart Disease

  Treatment of Anemia in Patients with Heart Disease...with Heart Disease Anemia is very common in patients with heart disease. About one-third...to 20% of those with coronary heart disease (CHD) are anemic. Anemia in patients

• Management Briefs eBrief-no106 -- Pharmacist-Led Chronic Disease Management: Effectiveness and Harms Compared to Usual Care

  ...eBrief-no106 -- Pharmacist-Led Chronic Disease Management: Effectiveness and Harms...Synthesis Program. Pharmacist-Led Chronic Disease Management: Effectiveness and Harms...found that pharmacist-led chronic disease management was generally similar to

• Management Briefs eBrief-no72 --

  ...hyperlipidemia, and cardiovascular disease are prime examples of chronic diseases that cause...protocol. For patients with elevated cardiovascular risk, interventions using nurse-managed

» View more Publications

» View more Cyberseminars

Videos

There are currently no videos for this topic.

Podcasts

There are currently no podcasts for this topic.

Other Resources

• VA and DoD agree on a common set of practice guidelines for a specific group of health conditions. Learn more about those guidelines here. 
• Visit the VA's Office of Research & Development healthcare topic overview section to learn more about milestones in VA heart disease research, read research updates, and download research fact sheets.
• Visit the ↑   Top
  
  
  Questions about the HSR&D website? Email the Web Team.
  
  Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.